SCHEMBL31751088

SCHEMBL31751088

CCOC(=O)Cc1c(Cl)ccc2c1c(C1CC1)nn2C1CCCCO1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.35
▸ RXRB P28702 1/20 0.35
▸ RXRG P48443 1/20 0.35
▸ DGAT2 Q96PD7 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ RET P07949 2/20 0.33
▸ P2RY12 Q9H244 1/20 0.32
▸ KDM4E B2RXH2 3/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ SLC6A3 Q01959 4/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ OPRK1 P41145 1/20 0.31
▸ SLC22A12 Q96S37 1/20 0.31
▸ CYP4F2 P78329 2/20 0.31
▸ CYP4A11 Q02928 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31750777 0.90 RXRA (0.36) RXRARXRBRXRGDGAT2P2RY12
SCHEMBL31750490 0.88 RXRA (0.35) RXRARXRBRXRGDGAT2P2RY12
SCHEMBL31750477 0.85 KDM4E (0.36) RXRARXRBRXRGDGAT2P2RY12
SCHEMBL31750140 0.81 DGAT2 (0.34) RXRARXRBRXRGDGAT2KDM4E
SCHEMBL31750142 0.80 RXRA (0.44) RXRARXRBRXRGDGAT2P2RY12
SCHEMBL31751095 0.79 HTR2C (0.34) DGAT2CNR1RET
SCHEMBL31750483 0.77 RXRA (0.33) RXRARXRBRXRGDGAT2P2RY12
SCHEMBL31750482 0.76 RXRA (0.42) RXRARXRBRXRGP2RY12KDM4E
SCHEMBL24495531 0.74 PPOX (0.38) RXRARXRBRXRGRETP2RY12
SCHEMBL28962275 0.73 RXRA (0.37) RXRARXRBRXRGDGAT2RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025262250-A1 GUANFACINE DERIVATIVES AND THEIR USES NEGIO THERAPEUTICS (BE) 2025-12-26 — — WO disclosed
Send feedback